New cancer clinical trial: Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies

Published on: February 27, 2018 at 12:00PM
Conditions:   Cancer;   Solid Tumor
Intervention:   Drug: RXC004
Sponsor:   Redx Pharma Plc
Recruiting
http://ift.tt/2HStxab